No logo added yet.
Hex Code
Color name
RGB
HSL
CMYK
#0062C3
Science Blue
0, 98, 195
210, 100, 38
100, 50, 0, 24
#5778B8
Steel Blue
87, 120, 184
220, 41, 53
53, 35, 0, 28
#0BC07B
Niagara
11, 192, 123
157, 89, 40
94, 0, 36, 25
The Accelerating Medicines Partnership in Common Metabolic Diseases (AMP-CMD) is a pivotal consortium that unites leading organizations including the NIDDK, FNIH, Amgen, Eli Lilly and Company, Novo Nordisk, and Pfizer Inc., along with academic and non-profit researchers. Based at the University of California San Diego, this initiative focuses on advancing research in common metabolic diseases through the development of the Common Metabolic Diseases Genome Atlas (CMDGA).
The CMDGA serves as a comprehensive resource that enhances understanding and treatment of prevalent conditions, including type 2 diabetes. Utilizing innovative software from the ENCODE DCC at Stanford University, the project aims to integrate data from multiple sources to foster collaboration and drive impactful insights into metabolic disorders. Furthermore, it features a user-friendly Common Metabolic Diseases Knowledge Portal and links to additional resources such as the Type 2 Diabetes Knowledge Portal. Funded by NIDDK, AMP-CMD represents a significant step forward in collaborative research that bridges academia and industry to combat metabolic diseases.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
What are CMDGA's brand colors?
The CMDGA color palette uses the hex codes #0062C3, #5778B8 and #0BC07B.
The CMDGA name, logos and brand assets are trademarks of CMDGA and its affiliates. Brandfetch isn't affiliated with or endorsed by CMDGA. Their use is subject to CMDGA's brand guidelines.
